Influence on voxel-based dosimetry: noise effect on absorbed dose dosimetry at single time-point versus sequential single-photon emission computed tomography

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Citação
NUCLEAR MEDICINE COMMUNICATIONS, v.44, n.7, p.596-603, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
ObjectiveThe purpose of this study was to evaluate how statistical fluctuation in single-photon emission computed tomography (SPECT) images propagate to absorbed dose maps. MethodsSPECT/computed tomography (CT) images of iodine-131 filled phantoms, using different acquisition and processing protocols, were evaluated using STRATOS software to assess the absorbed dose distribution at the voxel level. Absorbed dose values and coefficient of variation (COV) were analyzed for dosimetry based on single time-point SPECT images and time-integrated activities of SPECT sequences with low and high counts. ResultsConsidering dosimetry based on a single time-point, the mean absorbed dose was not significantly affected by total counts or reconstruction parameters, but the uniformity of the absorbed dose maps had an almost linear correlation with SPECT noise. When high- and low-count SPECT sequences were used to generate an absorbed dose map, the absorbed dose COV for each of the temporal sequences was slightly lower than the absorbed dose COV based on the single SPECT image with the highest count included in the sequence. ConclusionThe impact of changes in SPECT counts and reconstruction parameters is almost linear when dosimetry is based on isolated SPECT images, but less pronounced when dosimetry is based on sequential SPECTs.
Palavras-chave
in-vivo dosimetry, molecular imaging, nuclear medicine, single-photon emission computed tomography
Referências
  1. Amro H, 2010, J NUCL MED, V51, P654, DOI 10.2967/jnumed.109.067298
  2. Bardies M, 1996, PHYS MED BIOL, V41, P1941, DOI 10.1088/0031-9155/41/10/007
  3. Bergmann H., 2009, QUALITY ASSURANCE SP
  4. Bolch WE, 1999, J NUCL MED, V40, p11S
  5. Carvalho JWA., 2016, ALASBIMN J, V5, P1
  6. Cherry S.R., 2012, PHYS NUCL MED
  7. Dewaraja YK, 2013, J NUCL MED, V54, P2182, DOI 10.2967/jnumed.113.122390
  8. Dewaraja YK, 2012, J NUCL MED, V53, P1310, DOI 10.2967/jnumed.111.100123
  9. Dewaraja YK, 2010, J NUCL MED, V51, P1155, DOI 10.2967/jnumed.110.075176
  10. FAHEY FH, 1992, J NUCL MED, V33, P1859
  11. Gear J, 2020, EJNMMI PHYS, V7, DOI 10.1186/s40658-020-0282-7
  12. Gear JI, 2007, CANCER BIOTHER RADIO, V22, P166, DOI 10.1089/cbr.2007.305
  13. GRAHAM LS, 1995, MED PHYS, V22, P401, DOI 10.1118/1.597605
  14. Grassi E, 2015, PHYS MEDICA, V31, P72, DOI 10.1016/j.ejmp.2014.10.002
  15. He B, 2010, MED PHYS, V37, P1807, DOI 10.1118/1.3358119
  16. Hobbs RF, 2011, MED PHYS, V38, P2892, DOI 10.1118/1.3576051
  17. Kassis AI, 2008, SEMIN NUCL MED, V38, P358, DOI 10.1053/j.semnuclmed.2008.05.002
  18. Mikell JK, 2015, EJNMMI PHYS, V2, DOI 10.1186/s40658-015-0119-y
  19. Niemierko A, 1997, MED PHYS, V24, P103, DOI 10.1118/1.598063
  20. O'Donoghue JA, 1999, J NUCL MED, V40, P1337
  21. Rogers DWO, 2006, PHYS MED BIOL, V51, pR287, DOI 10.1088/0031-9155/51/13/R17
  22. Sapienza MT, 2019, CLINICS, V74, DOI 10.6061/clinics/2019/e835
  23. Sgouros George, 2021, Journal of the ICRU, V21, DOI 10.1177/14736691211060117
  24. Sgouros G, 2020, NAT REV DRUG DISCOV, V19, P589, DOI 10.1038/s41573-020-0073-9
  25. Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774
  26. Vaziri B, 2014, J NUCL MED, V55, P1557, DOI 10.2967/jnumed.113.131037
  27. ZANZONICO PB, 1989, SEMIN NUCL MED, V19, P47, DOI 10.1016/S0001-2998(89)80035-2